CARE Ratings DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.75×0.74×0.73×0.70×0.68×
1.28×1.29×1.34×1.44×1.42×
39.5%38.7%35.7%30.6%31.8%
0.46×0.46×0.45×0.41×0.36×
1.18×1.17×1.17×1.16×1.14×
20.4%19.8%18.4%14.7%12.5%
19.7%19.7%18.0%14.5%12.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CARERATING₹1,620.20

CARE Ratings Limited

· Banking & Finance
₹ CrorePeersICRAMcap ₹4,868 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.680.700.730.740.75
Interest Burden (Pretax/EBIT) ×1.421.441.341.291.28
EBIT Margin %31.8330.6535.7038.6939.55
Asset Turnover ×0.360.410.450.460.46
Financial Leverage (Assets/Equity) ×1.141.161.171.171.18
ROE (5-step product, year-end total equity) %12.5214.7318.3919.7820.44
ROE (owners' profit / average owners' equity) %12.3014.4718.0219.6919.69
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.